Table 3. Pooled adjusted seasonal vaccine effectiveness against influenza A(H3N2), by previous vaccination status, among those aged ≥ 9 years and by age group, by clade and genetic variants, I-MOVE primary care multicentre study, Europe, influenza season 2018/19 (n = 3,983).
Age group | Outcome | Previous vaccination status | Cases | Controls | Adjusted VE (%) | 95% CI (%) |
---|---|---|---|---|---|---|
≥ 9 years | A(H3N2) | Not vaccinated in either season | 1,147 | 2,061 | Ref | |
Vaccinated in 2018/19 only | 76 | 99 | −27 | −81 to 11 | ||
Vaccinated in 2017/18 only | 25 | 113 | 45 | 11 to 66 | ||
Vaccinated in both seasons | 153 | 309 | 5 | −23 to 27 | ||
15–64 years | A(H3N2) | Not vaccinated in either season | 852 | 1,719 | Ref | |
Vaccinated in 2018/19 only | 46 | 59 | −43 | −121 to 7 | ||
Vaccinated in 2017/18 only | 17 | 79 | 46 | 5 to 70 | ||
Vaccinated in both seasons | 69 | 116 | −14 | −62 to 20 | ||
≥ 65 years | A(H3N2) | Not vaccinated in either season | 91 | 152 | Ref | |
Vaccinated in 2018/19 only | 24 | 36 | 22 | −62 to 63 | ||
Vaccinated in 2017/18 only | 5 | 30 | 48 | −55 to 83 | ||
Vaccinated in both seasons | 78 | 184 | 31 | −9 to 56 | ||
≥ 9 years | Clade 3C.2a1b | Not vaccinated in either season | 209 | 1,492 | Ref | |
Vaccinated in 2018/19 only | 12 | 80 | −14 | −132 to 44 | ||
Vaccinated in 2017/18 only | 4 | 74 | NDa | |||
Vaccinated in both seasons | 36 | 203 | 49 | 17 to 69 | ||
≥ 9 years | Clade 3C.3a | Not vaccinated in either season | 94 | 930 | Ref | |
Vaccinated in 2018/19 only | 6 | 58 | −34 | −248 to 49 | ||
Vaccinated in 2017/18 only | 3 | 42 | NDa | |||
Vaccinated in both seasons | 20 | 163 | −122 | −353 to −9 |
a Omitted because of small sample size.
CI: confidence interval; ND: not done; Ref: reference value; VE: vaccine effectiveness.